The Fleischner Society, an international organization dedicated to thoracic imaging, periodically releases guidelines to standardize the management of incidentally detected pulmonary nodules. The recommendations published in 2017 provided an updated framework for assessing and following up on these nodules, based on size, morphology, and patient risk factors.
These guidelines are important because they offer a structured approach to evaluating pulmonary nodules, helping to reduce unnecessary imaging and invasive procedures while ensuring timely detection of lung cancer. The recommendations take into account the probability of malignancy based on nodule characteristics and patient history, allowing clinicians to tailor surveillance strategies appropriately. Prior to these guidelines, approaches to nodule management were often variable, potentially leading to over- or under-treatment.
